Therapy of obstetrical infections with moxalactam.
We evaluated moxalactam in 62 patients with puerperal or postabortal genital infections. In all patients, the initial dose was 6 g/day. In 84% of patients, we found anaerobes in genital specimens. Of aerobic isolates, only enterococci were resistant. Among anaerobes tested, only two isolates (a Clos...
Tallennettuna:
| Julkaisussa: | Antimicrob Agents Chemother |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology (ASM)
1980
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC283919/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6447473/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.17.6.1004 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|